Neovibsanin A and B are natural products which induced neurite outgrowth in PC12 cells. They belong in the neovibsane class under the rare vibsane natural product family, whose structures are characterized by polycyclic, polyoxygenated cores. Based on a proposed biosynthesis, the synthetic strategy towards neovibsanin A and B involved synthesizing a key enone intermediate. Initial investigation using this intermediate lead to the total synthesis of 2-O-methylneovibsanin H. Crucial to this concise synthesis was an acid-catalyzed, one-pot, four-step cascade reaction. Modifying the reaction condition leads to a different five-step cascade pathway, resulting in the total synthesis of 4,5-bis-epi-neovibsanin A and B. The synthetic trials and tribulations encountered on the road to these final compounds are explored. It is envisaged that other related neovibsane natural products may arise based on this synthetic sequence. 4,5-Bis-epi-neovibsanin A and B, as well as several other structural analogues collected during the synthesis, were biologically assayed using NGF-stimulated PC12 cells. All compounds induced a significant proportion of neurons to extend neurite processes compared to control cultures. The structure-activity relationship studies indicated that the tricyclic core, as well as the 3,3-dimethylacroyl enol ester side chain, may be responsible for promoting a biological response.

Neovibsanin A and B are natural products which induced neurite outgrowth in PC12 cells. They belong in the neovibsane class under the rare vibsane natural product family, whose structures are characterized by polycyclic, polyoxygenated cores. Based on a proposed biosynthesis, the synthetic strategy towards neovibsanin A and B involved synthesizing a key enone intermediate. Initial investigation using this intermediate lead to the total synthesis of 2-O-methylneovibsanin H. Crucial to this concise synthesis was an acid-catalyzed, one-pot, four-step cascade reaction. Modifying the reaction condition leads to a different five-step cascade pathway, resulting in the total synthesis of 4,5-bis-epi-neovibsanin A and B. The synthetic trials and tribulations encountered on the road to these final compounds are explored. It is envisaged that other related neovibsane natural products may arise based on this synthetic sequence. 4,5-Bis-epi-neovibsanin A and B, as well as several other structural analogues collected during the synthesis, were biologically assayed using NGF-stimulated PC12 cells. All compounds induced a significant proportion of neurons to extend neurite processes compared to control cultures. The structure-activity relationship studies indicated that the tricyclic core, as well as the 3,3-dimethylacroyl enol ester side chain, may be responsible for promoting a biological response.

Neovibsanin A and B are natural products which induced neurite outgrowth in PC12 cells. They belong in the neovibsane class under the rare vibsane natural product family, whose structures are characterized by polycyclic, polyoxygenated cores. Based on a proposed biosynthesis, the synthetic strategy towards neovibsanin A and B involved synthesizing a key enone intermediate. Initial investigation using this intermediate lead to the total synthesis of 2-O-methylneovibsanin H. Crucial to this concise synthesis was an acid-catalyzed, one-pot, four-step cascade reaction. Modifying the reaction condition leads to a different five-step cascade pathway, resulting in the total synthesis of 4,5-bis-epi-neovibsanin A and B. The synthetic trials and tribulations encountered on the road to these final compounds are explored. It is envisaged that other related neovibsane natural products may arise based on this synthetic sequence. 4,5-Bis-epi-neovibsanin A and B, as well as several other structural analogues collected during the synthesis, were biologically assayed using NGF-stimulated PC12 cells. All compounds induced a significant proportion of neurons to extend neurite processes compared to control cultures. The structure-activity relationship studies indicated that the tricyclic core, as well as the 3,3-dimethylacroyl enol ester side chain, may be responsible for promoting a biological response.

Neovibsanin A and B are natural products which induced neurite outgrowth in PC12 cells. They belong in the neovibsane class under the rare vibsane natural product family, whose structures are characterized by polycyclic, polyoxygenated cores. Based on a proposed biosynthesis, the synthetic strategy towards neovibsanin A and B involved synthesizing a key enone intermediate. Initial investigation using this intermediate lead to the total synthesis of 2-O-methylneovibsanin H. Crucial to this concise synthesis was an acid-catalyzed, one-pot, four-step cascade reaction. Modifying the reaction condition leads to a different five-step cascade pathway, resulting in the total synthesis of 4,5-bis-epi-neovibsanin A and B. The synthetic trials and tribulations encountered on the road to these final compounds are explored. It is envisaged that other related neovibsane natural products may arise based on this synthetic sequence. 4,5-Bis-epi-neovibsanin A and B, as well as several other structural analogues collected during the synthesis, were biologically assayed using NGF-stimulated PC12 cells. All compounds induced a significant proportion of neurons to extend neurite processes compared to control cultures. The structure-activity relationship studies indicated that the tricyclic core, as well as the 3,3-dimethylacroyl enol ester side chain, may be responsible for promoting a biological response.

Neovibsanin A and B are natural products which induced neurite outgrowth in PC12 cells. They belong in the neovibsane class under the rare vibsane natural product family, whose structures are characterized by polycyclic, polyoxygenated cores. Based on a proposed biosynthesis, the synthetic strategy towards neovibsanin A and B involved synthesizing a key enone intermediate. Initial investigation using this intermediate lead to the total synthesis of 2-O-methylneovibsanin H. Crucial to this concise synthesis was an acid-catalyzed, one-pot, four-step cascade reaction. Modifying the reaction condition leads to a different five-step cascade pathway, resulting in the total synthesis of 4,5-bis-epi-neovibsanin A and B. The synthetic trials and tribulations encountered on the road to these final compounds are explored. It is envisaged that other related neovibsane natural products may arise based on this synthetic sequence. 4,5-Bis-epi-neovibsanin A and B, as well as several other structural analogues collected during the synthesis, were biologically assayed using NGF-stimulated PC12 cells. All compounds induced a significant proportion of neurons to extend neurite processes compared to control cultures. The structure-activity relationship studies indicated that the tricyclic core, as well as the 3,3-dimethylacroyl enol ester side chain, may be responsible for promoting a biological response.

Branching is a highly plastic trait, enabling plants to adapt their growth form in response to environmental stimuli. In flowering plants, shoot branching is regulated through the activity of axillary buds, which grow into branches. Several classes of plant hormones have been shown to play pivotal roles in regulating bud outgrowth. Auxin derived from the primary shoot apex and active branches inhibits bud outgrowth, whereas cytokinin promotes it. Strigolactones also inhibit bud outgrowth, by changing properties of the auxin transport network, increasing the competition between buds. This occurs by modulating access to the polar auxin transport stream (PATS) in the main stem. The PATS provides directional, long distance transport of auxin down the stem, involving basal localisation of the auxin transporter PIN-FORMED1 (PIN1). Buds need to export their auxin across the stem towards the PATS in order to activate, but since PIN1 is mainly expressed in narrow files of cells associated with the stem vasculature, PIN1 itself it is unlikely to facilitate this connectivity. This thesis re-examines the role of auxin transport in the stem, showing that, besides the PIN1-mediated PATS, other auxin transport proteins constitute a more widespread and less polar auxin transport stream, allowing auxin exchange between the PATS and surrounding tissues. Disruption of this transport stream is shown to reduce bud-bud communication and to partially rescue the increased branching observed in strigolactone mutants. Furthermore, it is shown that distinct classes of auxin transport proteins within this stream can differentially affect bud outgrowth mediated by BRANCHED1 (BRC1). BRC1 is a transcription factor proposed to determine bud activation potential. Taken together, the data presented here provide a more comprehensive understanding of the shoot auxin transport network and its role in shoot branching regulation.

Le striatum est composé principalement de neurones épineux de taille moyenne, subdivisés en neurones striatopallidaux et striatonigraux en fonction de leurs projections et de leur expression en récepteurs et neuropeptides. Ces deux populations neuronales sont respectivement à l’origine des voies indirecte (ou inhibitrice) et directe (ou activatrice) des noyaux de la base, présentant des effets opposés à la fois au niveau moteur et motivationnel. Ces deux voies sont également différemment affectées dans différentes pathologies des noyaux de la base, telles que les maladies de Huntington et de Parkinson et les addictions. Les mécanismes moléculaires et cellulaires de régulation des neurones STP et STN ne sont cependant pas encore pleinement compris. Dès lors, l’identification et l’étude de la fonction de gènes spécifiques de l’une ou l’autre de ces sous-populations pourraient constituer une étape importante vers une meilleure compréhension de leur fonctionnement. Dans cette optique, notre laboratoire a précédemment réalisé une étude comparative des profils d’expression de chacune des sous-populations striatales par microarray. Parmi les gènes potentiellement inégalement exprimés dans les neurones STP et STN, nous avons identifié GPRIN3, un membre de la famille G Protein-Regulated Inducer of Neurite outgrowth (GPRIN), comme étant une cible intéressante. Cette famille, bien qu’encore très peu caractérisée, interagit en effet avec les sous-unités Gαi/o des protéines G et joue par conséquent un rôle régulateur sur la fonction et la voie de signalisation de certains GPCRs, tels que le récepteur μ opioïde. De plus, contrairement aux autres membres de la famille GPRIN, nos résultats de microarray suggèrent également un niveau d’expression élevé de GPRIN3 dans les neurones striataux chez l’adulte. Etant donné le rôle crucial des GPCRs au niveau du striatum et plus particulièrement dans le comportement différentiel des neurones STP et STN, GPRIN3 pourrait dès lors constituer un élément important dans le fonctionnement des neurones striataux. Ce travail s'est par conséquent axé sur l’élucidation du rôle de GPRIN3 dans les fonctions striatales. Dans ce but, nous avons dans un premier temps établi le profil d'expression de GPRIN3 chez la souris, au niveau du cerveau adulte et lors de l'embryogénèse. Ceci nous a permis de confirmer, chez l'adulte, l'expression majoritairement striatale de GPRIN3, et l'expression préférentielle dans les neurones STP. Nous avons également généré différents vecteurs d'expression de la protéine GPRIN3 et établi sa localisation subcellulaire en lignée HEK293T. La génération et la caractérisation d'un modèle d'invalidation constitutive ainsi que d'un modèle de répression par interférence ARN ont par la suite mis en évidence une implication, directe ou indirecte, de GPRIN3 dans la régulation fine de la signalisation du D2R. En effet, nous avons montré une modification des comportements liés à la motivation et à la réponse à la cocaïne ainsi qu’une altération de l’état de phosphorylation de DARPP32 et de la réponse à l’halopéridol dans le modèle d’invalidation constitutive. De plus, la réponse au quinpirole est également modifiée dans les deux modèles testés. Pris dans leur ensemble, ces résultats suggèrent dès lors une altération de la voie de signalisation du D2R en l’absence de GPRIN3 fonctionnel. En outre, les neurones STP dépourvus de GPRIN3 fonctionnel présentent des modifications de leur morphologie et de leurs propriétés électrophysiologiques. En conclusion, ce travail de thèse a permis d’apporter les premières pistes quant à la fonction de GPRIN3, une protéine totalement méconnue, dans le striatum, de par la création de modèles d’invalidation constitutive et de répression Cre-dépendante de cette protéine. Divers outils moléculaires ont également été générés et pourront être utilisés dans la suite de la caractérisation des fonctions de GPRIN3. / Doctorat en Sciences biomédicales et pharmaceutiques (Médecine) / info:eu-repo/semantics/nonPublished

Le développement des bactéries sporulées dans les aliments peut être responsable d’intoxication alimentaire ou d’altérations des produits. Trois leviers ont été identifiés pour prévenir le développement de ce microbiote : les conditions de sporulation, l’intensité du traitement appliqué pour inactiver les spores et les conditions d’incubation. Ce travail de thèse a pour objectif (i) de quantifier l’impact des conditions de sporulation, de traitement et d’incubation sur la capacité des spores à former des colonies, et (ii) de quantifier l’impact des conditions de sporulation, de traitement et d’incubation sur les cinétiques de germination et de reprise de croissance. Dans un premier temps, un modèle mathématique a été développé pour décrire et quantifier l’impact des conditions d’incubation sur la capacité des spores à former des colonies après un traitement thermique. Ce modèle intègre uniquement des paramètres physiologiques, les limites de croissance des souches étudiées. La germination et la reprise de croissance est un processus complexe au cours duquel les spores passent par plusieurs stades successifs : spores dormantes, spores germées et cellules végétatives. Afin de quantifier l’impact des conditions de sporulation, de traitement thermique et d’incubation sur chacun de ces stades, une méthode par cytométrie en flux a été développée. Elle a permis de suivre l’évolution de chaque stade au cours du temps et un modèle primaire a été proposé afin de décrire l’évolution de chacun de ces stades. A partir de ce modèle il a été possible de décrire l’impact des différentes conditions de sporulation, de traitement thermique et d’incubation sur cette évolution et un modèle secondaire a été développé pour quantifier l’impact de ces facteurs sur les cinétiques de germination et de reprise de croissance. Afin de corréler les différences de comportement avec la composition protéique des spores, une analyse protéomique a été réalisée sur des spores produites dans différentes conditions. Ces travaux permettent de mieux appréhender le comportement de germination et de reprise de croissance des spores bactériennes. De plus, les résultats apportés ainsi que les modèles mathématiques développés dans cette thèse pourront permettre de mieux contrôler le développement des bactéries sporulées en industrie agro-alimentaire, connaissant l’impact des conditions de stockage et de formulation des produits, comme la température et le pH, sur le comportement des spores. / The development of spore forming bacteria in foods can be responsible for food poisoning or food spoilage. Three levers allowing the development of this microbiota were identified: the conditions of sporulation, the conditions of heat treatment and the conditions of incubation. This PhD work objectives were (i) to quantify the impact of sporulation conditions, heat treatment intensity and recovery conditions of the ability of spores to form colonies, and (ii) to quantify the impact of sporulation conditions, heat treatment intensity and recovery conditions on germination and outgrowth kinetics. Firstly, a mathematical model was developed to describe and quantify the impact of recovery conditions on the spore ability to form colonies a heat treatment. This model integrated only physiological parameters, the growth limits. The germination and outgrowth is a complex process made of successive physiological stages the spores pass through: the dormant spores, the germinated spores and the vegetative cells. A flow cytometry method was developed in order to quantify the impact of sporulation conditions, the heat treatment intensity and the incubation conditions on each physiological stage. This method allowed monitoring the evolution of each stage over time and a primary model was proposed to describe these evolutions. Thanks to this model, the impact of sporulation conditions, the heat treatment intensity and the incubation conditions were quantified and a secondary model was developed to quantify the impact of these factors on germination and outgrowth kinetics. In order to correlate the differences of behavior with the proteome of spores, proteomic analysis were performed on spores produced in different conditions. This work allows a better comprehension of germination and outgrowth behavior. Moreover, the results and the mathematical models provided by this work can be applied in food industry to improve the control of spores forming bacteria development knowing the impact of storage conditions and the product formulation, like temperature and pH, on spore behavior.

Recent advances in cellular reprogramming have enabled the generation of embryoniclike cells from virtually any cell of the body. These inducible pluripotent stem cells (iPSCs) are capable of indefinite self-renewal while maintaining the ability to differentiate into all cell types. Nowhere will this technology have a greater impact than in the ability to generate disease and patient-specific cell lines. Here we explore the capacity of human iPSCs reprogrammed from peripheral blood endothelial progenitor cells lines to differentiate into atrial myocytes for the study of patient specific atrial physiology. Methods and Results: Late outgrowth endothelial progenitor cells (EPCs) cultured from clinical blood samples provided a robust cell source for genetic reprogramming. Transcriptome analysis hinted that EPCs would be comparatively more amenable to pluripotent reprogramming than the traditional dermal fibroblast. After 6 passages, EPCs were transduced with a doxycycline inducible lentivirus system encoding human transcription factors OCT4, SOX2, KLF4 and Nanog to permit differentiation after removal of doxycycline. The high endogenous expression of key pluripotency transcripts enhanced the ease of iPSC generation as demonstrated by the rapid emergence of typical iPSC colonies. Following removal of doxycycline, genetically reprogrammed EPC-iPSC colonies displayed phenotypic characteristics identical to human embryonic stem cells and expressed high levels of the pluripotent markers SSEA-4, TRA1-60 and TRA1-81. After exposure to conditions known to favor atrial identity, EPC- iPSC differentiating into sheets of beating cardiomyocytes that expressed high levels of several atrial-specific expressed genes (CACNA1H, KCNA5, and MYL4). Conclusions: EPCs provide a stable platform for genetic reprogramming into a pluripotent state using a doxycycline conditional expression system that avoids reexpression of oncogenic/pluripotent factors. Human EPC-derived iPSC can be differentiated into functional cardiomyocytes that express characteristic markers of atrial identity.

Le développement cérébral est une succession d'étapes aboutissant à l'établissement d'un réseau neuronal. Il fait intervenir de nombreuses molécules comme des protéines d'adhésion permettant l'interaction des neurones avec leur environnement. L'implication de nombreux gènes codant des protéines d'adhésion dans la physiopathologie de maladies neuropsychiatriques comme l'autisme souligne l'intérêt à en identifier de nouveaux. Pendant ma thèse, j'ai pu caractériser deux nouveaux gènes, Susd2 et Susd4, codant des protéines contenant des domaines CCP (Complement Control Protein), classiquement connus pour leur présence dans les protéines participant à la régulation du système du Complément. Récemment, des protéines à domaines CCP ont été décrites chez la souris comme ayant une fonction dans le développement neuronal. L'existence de nombreuses protéines prédites à domaines CCP sans fonction connue m'ont conduit à tenter de caractériser Susd2 et Susd4 qui en font partie.Susd2 est exprimé dans les neurones au sein de cultures de cellules d'hippocampe de rat. Son expression atteint un pic à un stade post natal précoce, suggérant une fonction développementale. La protéine Susd2 recombinante a une localisation neuronale diffuse, mais est particulièrement enrichie dans les synapses excitatrices. La diminution de l'expression de Susd2 a pour conséquences un défaut de croissance axonale, une augmentation de la croissance dendritique, et une inhibition spécifique de la synaptogénèse excitatrice. Susd4 est également exprimé dans les neurones, avec un pic d'expression au stade embryonnaire, et semble jouer un rôle de régulation du développement dendritique. / During brain development, several steps precisely coordinated lead to establishment of a functional neuronal network. Many molecules participate to this process, including adhesion proteins mediating interactions between neurons and their environment. Involvement of numerous genes coding for adhesion proteins in neuropsychiatric diseases such as autism argue for usefulness of identifying new ones. During my PhD, I characterized two new genes, Sud2 and Susd4, coding for proteins containing CCP domains (Complement Control Protein), classically described in proteins involved in Complement regulation system. Recently, in mammals, CCP containing proteins were shown to be involved in neuronal development. Identification of several predicted CCP containing proteins without a known function prompted me to characterize Susd2 and Susd4 which are part of them.Susd2 is expressed in neurons from hippocampal cell cultures. Its peak of expression takes place in early post natal period, suggesting a developmental function. Susd2 recombinant protein has a diffuse neuronal localization, but is particularly enriched in excitatory synapses. Decreased expression of Susd2 leads to decreased axonal growth, increased dendritic growth, and specific inhibition of excitatory synaptogenesis. Susd4 is also expressed in neurons, with a peak of expression during embryonic development, and seems to act as a regulator of dendritic growth.